Lacosamide injection for stopping prolonged seizures
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests an injectable medicine (lacosamide) to quickly stop a seizure emergency called status epilepticus, where seizures last longer than normal. It may help people who are having a seizure that won't stop on its own.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 4 and 60 years old
- You are having a seizure lasting more than 5 minutes, or repeated seizures without waking up in between
- You or your guardian agree to the study and sign a consent form
- Your vital signs (like breathing and heart rate) are stable
- You do not have a heart rhythm problem like atrial flutter or atrial fibrillation
- You are not allergic to lacosamide or similar drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding ketamine to standard care can stop seizures that continue after a first treatment. It is for people having a convulsive seizure lasting more than 5 minutes and who are still seizing in the emergency room.
This trial is for adults in the intensive care unit who are having seizures that last at least 5 minutes or keep coming back without fully recovering. It tests a study approach for managing a dangerous seizure emergency and may help doctors improve care for critically ill patients.
This trial tests whether taking ketone esters (a special form of ketones) can help stop refractory generalized convulsive status epilepticus (a seizure emergency that is hard to control). If you qualify, the study team will check safety closely, especially your breathing, heart stability, and blood sugar/acid levels.
This trial tests a new implanted device that detects and stops seizures before they spread. It is for people with difficult-to-control focal seizures who have not had success with medicines.
This Phase 2 trial tests a medication strategy to stop “refractory status epilepticus,” a severe seizure condition that can happen after a cardiac arrest. It may help by reducing ongoing seizure activity after return of circulation in the ICU.
This trial studies whether using EEG (a brain-wave test) in the ICU can help guide care for people whose seizures keep going despite initial medicines. It may benefit patients with severe, difficult-to-stop status epilepticus by improving how doctors find and treat ongoing seizure activity.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.